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ABSTRACT
Wilson, Patrick. Characterizing of Monoamine Neurotransmitters at the Hub of the Central
Auditory System. Unpublished Master of Science thesis, University of Northern
Colorado, 2021.

In the United States, loss of hearing impacts approximately 48.1 million people. The
cumulative effects of noise are experienced in every area of society whether occupational,
environmental, or through aging. A number of studies have linked noise induced hearing
disorders to changes in spontaneous neuronal activity in certain auditory brain regions,
especially, the inferior colliculus, a region that integrates auditory inputs from both ascending
and descending pathways. However, the exact neurochemical basis of these disorders remains
elusive. Currently, there are several compelling pieces of evidence that implicate the monoamine
neurotransmitter, dopamine, in auditory processing. Based on this data, we have hypothesized
that changes in the dopamine system within the inferior colliculus would contribute to the neural
dysfunction underlining noise induced hearing loss. To examine this hypothesis, 32 Adult
Sprague Dawley rats were used. The present work optimized a fast scan cyclic voltammetry
(FSCV) assay and used it to characterize the dopamine system in rat brain, then examined the
impact of loud noise on the system and finally, explore possible mechanisms underlying noise
induced changes in the system. The FSCV assay provided the speed, selectivity, sensitivity, and
the spatial resolution needed for the neurochemical measurement. The assay also allowed
simultaneous detection and monitoring of both dopamine and another monoamine,
norepinephrine in the inferior colliculus for the first time. These signals were pharmacologically
iii

confirmed and were found to be significantly and simultaneously attenuated by exposure to loud
noise that has been characterized to cause permanent deafness. This data suggest that
monoamines may play a crucial role in auditory processing and that changes in both dopamine
and norepinephrine neurotransmissions are associated with noise induced hearing loss. D2
receptor functionality was examined as a possible mediator of the noise-induced changes in the
dopamine neurotransmission, but revealed no significantly alteration following noise exposure.
Nonetheless, immunocytochemistry data demonstrated noise-induced attenuation in the receptor
distribution in the inferior colliculus, an effect that implicate the D2 receptors in deafness related
changes in the inferior colliculus. Overall, the combination of FSCV and immunocytochemistry
provided new insights and sets the stage to further understand the role of monoamines in the
central auditory processes.
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CHAPTER 1
INTRODUCTION
Hearing-related disorders are prevalent all over the world and can be caused by exposure
to loud noise encountered through recreation, or occupation. In the United States, the effects of
hearing loss impact approximately 48.1 million people (F. R. Lin et al., 2011). Evaluations by
the Centers for Disease Control and Prevention (CDC) indicate nearly a quarter (24%) of
working adults have a proclivity for noise-induced hearing loss (Carroll, 2017). Of these working
adults, approximately 30 million are exposed to hazardous levels of noise with another 9 million
exposed to ototoxic chemicals (Yankaskas, 2013). Veterans stand apart as a uniquely impacted
group, according to the Department of Veteran’s Affairs, with tinnitus and hearing loss being the
top two disability claims. These two disabilities result in $1.8 billion in estimated compensation
(Huddle et al., 2017). Tinnitus differs from hearing loss and is described as the development of
acoustic phantoms, which are characterized as persistent ringing and/or buzzing sounds in the
ear. Currently, there are no objective measures for how tinnitus is measured or diagnosed aside
from qualitative means. Furthermore, the extent of damage that noise can impart upon the brain
is not well understood.
A number of studies have reported the effects of noise on the central auditory system,
with most of these studies suggesting that exposures to loud noise trigger spontaneous neuronal
activity in auditory brain regions (Chen et al., 2016; Basta & Ernest, 2004; J. S. Zhang &
Kaltenbach, 1998). Further growing evidence suggests a connection between the peripheral
effects of noise damage with central consequences in the nervous system. A comparative study
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between tinnitus and non-tinnitus patients utilizing functional magnetic resonance imaging
(fMRI) demonstrates increased activation of the inferior colliculus by sound stimulation
(Middleton & Tzounopoulos, 2012). This effect has also been exemplified by a similar study
using Magnetic Resonance Imaging (MRI), which indicated a reduction in glucose metabolism
within areas of the auditory cortex and inferior colliculus from individuals suffering from
hearing loss (Speck et al., 2020). Furthermore, patients with central nervous system pathology,
like Parkinson’s disease, associated with depletion of dopamine, exhibit a proclivity towards
deficits in their auditory processing (Folmer et al., 2017; Lai et al., 2014). This observation
implicates monoamines, like dopamine, in auditory processing.
Dopamine is a neurotransmitter well-known for its role in learning, memory, cognition,
voluntary movement, and reward-related behaviors, but is not typically associated with hearing.
Currently, however, significant amounts of data exist that suggest dopamine’s role in hearing.
For instance, changes in tyrosine hydroxylase (TH), the rate-limiting enzyme in dopamine
synthesis, and dopamine receptor gene expressions have been reported in the dorsal cortex and
the central nucleus of the inferior colliculus, and also within the intermediate lemniscus
following deafness (Tong et al., 2005). A follow-up study also indicates these changes persist in
the cochlear nucleus and inferior colliculus following acoustic trauma (Fyk-Kolodziej et al.,
2015). Electrophysiological experiments have shown dopamine within the inferior colliculus
affects auditory responses in a heterogeneous manner (Gittelman et al., 2013a). Despite the
presence of this evidence, the way dopamine neurotransmission modulates auditory processes,
particularly within the inferior colliculus, is still not well understood.
The present work was designed to bridge this gap by first, optimizing an electroanalytical
method, fast scan cyclic voltammetry (FSCV) to detect, characterize, and quantify monoamine
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release and uptake within the inferior colliculus. The inferior colliculus is an important brain
region in the central auditory pathway, as it integrates auditory inputs from both ascending and
descending pathways. Tract tracing and electrochemical studies have demonstrated that
dopaminergic neurons in the subparafasicular thalamic nucleus (SPF), a non-auditory region,
innervate the inferior colliculus (Batton, et al., 2019; Nevue, et al., 2016). This suggests nonaudiologic neurons have a connection and role in auditory processing.
Second, the effects of loud noise on monoamine neurotransmission were characterized
and compared. This objective was achieved utilizing FSCV with pharmacological manipulations.
Previous comparisons between deaf and normal subjects have displayed a marked-down
expression for both enkephalin, an opioid receptor, and tyrosine hydroxylase (TH), respectively
(Holt et al., 2005a). This suggests a lack of expression of dopamine synthesis from TH would
result in an overall downstream decrease in affected dopamine neurons.
Third, the mechanism behind monoamine activity within the inferior colliculus was
explored by examining dopamine receptor functionality. Dopamine receptors are categorized
into D1-like and D2-like receptors. The D1-like receptors are involved in excitatory functions,
whereas the D2-like receptors are inhibitory in their action. Characterizing these receptors in the
inferior colliculus will provide information about the type of dopaminergic transmission that
predominates the region. This objective was achieved through the combination of FSCV with
pharmacology and immunoassays, such as immunocytochemistry.
Altogether, this proposed work laid the necessary foundations towards understanding the
role of monoamines in hearing. Furthermore, insight garnered from this work may contribute to
both a route for therapeutic innovations, and the development of objective measures towards
characterizing noise-induced hearing disorders.
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1.1 Specific Research Objectives
Although substantial research data exist to implicate dopamine in processes both in the
peripheral and central auditory pathway, the specific neural action of the neurotransmitter is not
known. The presented work focused on the inferior colliculus to begin to define the neural action
of dopamine neurotransmission in the central auditory pathway. The inferior colliculus acts as
the integration center for both ascending and descending neural auditory pathways. The region
also receives innervations from non-auditory neural sources. Herein, dopamine’s neural action in
the inferior colliculus was explored under three main objectives.
O1

Optimization of a FSCV assay to characterize dopamine neurotransmission in the
inferior colliculus.

The inferior colliculus has been extensively studied using techniques, such as soundevoked responses (Shaheen & Liberman, 2018), frequency-followed responses (Wang & Li,
2018), and electrophysiology (Gittelman et al., 2013a). However, the role of dopamine
neurotransmission in the inferior colliculus has not been characterized. Recently, retrograde
tracing has been used to identify the subparafasciular thalamic nucleus (SPF) as a source of
dopamine in the inferior colliculus. In that experiment, the SPF was found to be the only nucleus
where the retrograde label was detected in connection with the inferior colliculus, hence
establishing the SPF as the primary source of dopamine to the inferior colliculus (Nevue et al.,
2016). The present work was built on this foundation by characterizing the dopamine
neurotransmission in the inferior colliculus using slice fast scan cyclic voltammetry (FSCV).
Herein, the FSCV technique was optimized by characterizing the figures of merit for dopamine
detection and differentiating the sensitivity from interfering analytes.
O2

Characterizing the effects of loud noise on monoamine neurotransmission in the
inferior colliculus.
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Existing data has demonstrated change in tyrosine hydroxylase gene expression is
significantly reduced following acoustic trauma (Fyk-Kolodziej et al., 2015; Holt et al., 2005b;
Tong et al., 2005). These changes suggest that dopamine is involved in deafness- related
plasticity in the inferior colliculus. Based upon this data, we hypothesize that loud noise could
alter the dopamine neurotransmission in the inferior colliculus. The present objective thus,
examines the effects of noise on the dopamine release and uptake, as well as the functionality of
dopamine receptors. Comparative FSCV experiments was be performed between control and
sound exposed subjects to indicate the effects on dopamine neurotransmission. This work
provided insight about the neuronal basis of noise induced hearing deficit and could pave way
for future interventions and therapies.
O3

Exploring a plausible mechanism underlying the deafness- related changes in
monoamine neurotransmission.

Dopamine’s activity can be functionally described by which types of receptors are
present. Two primary receptor families are associated with dopamine transmission, namely D1like and D2-like receptors (Jaber et al., 1996). Five subclassifications further characterize these
receptors according to their more specific neurological function. While dopamine receptor gene
expression has been reported in the inferior colliculus (Fyk-Kolodziej et al., 2015), neither the
levels, nor the functionality of these receptors has been shown. Under this objective, both the
levels and the functionality of D1 excitatory and D2 inhibitory receptors were characterized, and
we sought to understand whether the dopaminergic inputs in the inferior colliculus are excitatory
or inhibitory in their function. This also provided insight as to the role dopamine may play in the
inferior colliculus.
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CHAPTER 2
LITERATURE REVIEW
2.1 Sound Processing Through the Auditory

Nervous System
The path of sound through the auditory system is essentially similar across all mammals.
Soundwaves are collected by the pinna, much like a funnel. Here, the waves are transmitted
through the auditory canal until reaching the eardrum, or tympanic membrane. The sound wave
vibrates the tympanic membrane, causing the movement of a series of bones within the middle
ear. These bones are the malleus, incus, and stapes (Figure 1). The vibration of these bones
subsequently moves a vast multitude of tiny hair cells in a snail-shaped structure called the
cochlea. Through electro-mechanical transduction, the hair cells transform the vibrational
patterns of sound into neural signals. The stretching sensation of the hairs triggers ion channels
resulting in the creation of an action potential, the electrical impulse which transmits neural
messages. The passage of signal from the cochlear hair cells into the vestibulocochlear nerve
(cranial nerve VIII) marks the transition from the peripheral to the central auditory pathway.
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Figure 1. A cross sectional view of the peripheral auditory anatomy.
Input from the vestibulocochlear nerve ascends through a series of neural nuclei until
reaching the auditory cortex, where the sound is ultimately perceived (Figure 2). The connection
with the auditory cortex is achieved through several neural relays. First, the message is received
at the cochlear nuclei within the brainstem. Most of the signal decoding happens here, which is
responsible for discerning the frequency, duration, and intensity of the soundwave. Next,
continuing further within the brainstem, is the superior olivary complex. Sound localization
begins here, where the majority of the auditory nerves cross the brainstem’s midline. Third, the
lateral lemniscus contains the connections from the contralateral cochlear nuclei, with the
ipsilateral superior olivary complex forming a single tract. These fibers ascend further,
converging at the inferior colliculus (Cope et al., 2015). At the inferior colliculus, both the
ascending and descending auditory pathways are conserved. Due to the extensive integration of
auditory and non-auditory neural inputs, the inferior colliculus is commonly referred to as the
call center of the central auditory system. The last relay before entering the auditory cortex is the
medial geniculate body, which is responsible for the integration of the sound information in
preparation for other actions (Peterson & Hamel, 2019). Ending at the auditory cortex, the neural

8
signal has been decoded, recognized, and can be further memorized and/or integrated into a
response.

Figure 2. Overview of the central auditory system. Neural innervations entering the brain from
the cochlea. Auditory inputs integrated at the inferior colliculus.
2.2 Neurotransmission and Neurochemicals
The functional activity within the nervous system operates through the reception of
stimulating input and the means by which these signals are processed. Propagation of these
neural messages through the nervous system defines neurotransmission. Following the delivery
of a stimulus, neurons conduct these signals through an electrochemical gradient called an action
potential. These electrical potentials are achieved through the multitude of ion channels and
pumps located along the neuron, which create a charge disparity between the nerve terminal and
the extracellular space. These ions produce a gradient of charge that creates the environment,
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providing the electric pulse to move down the nerve terminal quickly and efficiently, much like
the flow of electrons through a wire.
Unlike wires, which exist as one continuous connector to another, nerve terminals are
separated by a small gap between the clefts of the neural cells, called the synapse or synaptic
cleft. The intricacies of these neural protein receptors at this junction is where the nuance of the
nervous system is expressed. These neurons contain myriad neurochemicals which are released
to propagate a specific signal in response to the invoked stimulus. Categorized as
neurotransmitters, these molecules are chiefly responsible for the diversity of operations carried
out by the nervous system. Following the synthesis of these neurochemicals, they are packaged
within vesicles waiting for the activity of an action potential to foster their release.
Dopamine is a neurotransmitter widely known for its role in learning, memory, cognition,
and reward-related behaviors. The pathway of dopamine synthesis classically begins with
conversion of L-phenylalanine into L-tyrosine. Enzymatic hydroxylation catalyzed by tyrosine
hydroxylase (TH) produces L-3,4-dihydroxyphenylalanine (L-DOPA), a catechol moiety.
Decarboxylation of L-DOPA from aromatic amino acid decarboxylase (AADC) yields dopamine
(Figure 3). Next, dopamine is either packaged into vesicles for later use or shuttled further down
the catecholamine synthetic pathway and converted into norepinephrine.
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Figure 3. Summary of dopamine synthesis occurring within the cytosol of neural cell bodies.
As the electrical impulse passes down the nerve fiber, it eventually reaches an endpoint
along the axon terminal where the neurochemically loaded vesicles are signaled to fuse with the
cell’s outer membrane, releasing their contents into the synaptic cleft (Figure 4). These released
neurochemicals then seek to bind to specific receptors on the receiving nerve terminal to further
propagate the neural message. Previously bound, as well as unbound and excess,
neurotransmitters are either recycled back into their sending neuron or degraded into metabolites
within the synaptic space.
Dopamine is broken down through a series of enzymatic reactions. The order of this
process is sometimes variable, due to the complex nature of dopamine neurotransmission. Either
through monoamine oxidase, catechol-O-methyl transferase, or aldehyde dehydrogenase, the
final metabolic end product is homovanillic acid (Figure 5).
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Figure 4. Generalized diagram of dopamine neurotransmission. Action potentials facilitate
neurotransmitter release into the synaptic space where neurochemicals interact with target
receptors. Binding further propagates physiological responses, such as learning, reward, motion,
etc. Unused chemicals are either recycled or metabolized.
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Figure 5. Summary of dopamine metabolism. The order of each enzymatic process is not
exclusive to a singular pathway and may involve a different order.
Dopamine-based receptors are organized into two distinct families (D1-like and D2-like)
(Jaber et al., 1996). D1-like receptors are multi-functionally associated with the reward pathwaylearning, locomotion, and memory. These receptors are excitatory and enhance neuronal activity.
In contrast, the D2-like receptors are inhibitory in nature, suppressing neuronal excitability and
inhibiting dopamine release. Receptor distribution within the brain region of interest can help
shed light on which neurological function, inhibitory or excitatory, predominates.
2.3 Tools for Brain Measurements
For a technique to be suitable for neurochemical measurements, it must have high spatial
resolution, speed, sensitivity, and selectivity (Lama et al., 2012). Nerve terminals have already
been established to be small, and the amounts of neurochemicals transferred are as equally
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minute. Low concentrations of neurochemicals necessitate the selection of an instrumental
method capable of detecting the analyte, while also being able to discriminate against the
background signal. The most commonly used techniques for neurochemical measurements
include imaging, sampling, and separation tools, such as microdialysis coupled to
chromatography, and electroanalytical techniques.
Imaging methods extend throughout a broad application in both research and medicine.
Visualization of neural environments can span the entire brain, using tools such as MRI (Ferraro
et al., 2014), positron emission tomography (PET) scans (Tuominen et al., 2014), or
radioactivity. Utilization of contrast agents, such as fluorescent probes (M. Z. Lin & Schnitzer,
2016) or nanoparticles (Moussaron et al., 2015), become necessary to properly view the neural
dynamics of the system. Many of these methods provide non-invasive means for testing neural
environments in vivo.
Though the field of imaging continues to improve and evolve, the implementation in
neuroscience research faces many challenges. Primarily, the cost of such detection systems
becomes inhibitory in and of itself, with many of the instruments ranging from hundreds of
thousands of dollars. The usage of complex and expensive contrast and detection agents only
limit the usage of these imaging techniques in neuroscience research. The intricacy of both the
instrumentation and the subjects of study also further the difficulties of these techniques in more
common practice.
Sampling and separating methods provide the unique capabilities of monitoring and
detecting analytes simultaneously. Most of these techniques seek to quantify neurochemicals,
and their associated substituents, extracellularly. Common examples include microdialysis (Gu et
al., 2015; H. Yang et al., 2013) and high-performance liquid chromatography (HPLC) (Schou-
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Pedersen et al., 2016). These methods effectively maintain specimen viability while allowing
incorporation of different detection capabilities. The diversity of the instrumental components
provides an approach to adaptability of the analytical tool in the face of separating out the bulk
tissue components. Separation methods operate most efficiently when the samples are previously
extracted for analysis.
Compared with the other categories, imaging and electrochemistry, sampling/separation
methods are limited in temporal resolution. Large probes used in microdialysis also create issues
in spatial resolution. The tissue becomes disrupted creating peripheral damage and inviting host
immune responses. Reproducibility is also restricted with these methods, as much of the initial
sample can become degraded or destroyed during the data acquisition process. However, the vast
array of options available under these techniques will continue to provide an essential tool in
analytical analysis.
Electrochemical detection of neurochemicals was first characterized in the 1980s. Since
then, techniques such as amperometry and voltammetry have provided expansive information of
electroactive chemicals involved in neurotransmission, chiefly through alterations in analyte
redox potentials along the varying electrode surfaces. This early work has become the foundation
of several present clinical and research instrumentations (Webster, 2009). These methods mainly
seek the analysis of neurotransmitters through either cellular exocytosis, in vitro or in vivo
experimentation. The highly sensitive and temporal resolution of these techniques make them
ideal for neuroscience research.
Exocytosis techniques, including amperometry, are most useful when studying
neurotransmitter release (Lemaître et al., 2014). Comparison of chemical release across differing
cell types is where these types of instruments excel. The quantity of neurochemicals released
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does not convey the total amount present in the neuron, as most of the content of neurochemicals
within their vesicles is retained. The inability to gauge the number of secretory neurochemicals
remains a consistent critique of these techniques. Enhancement of microfluidics has yielded
promise in expanding such techniques beyond neurochemical research.
In vitro and in vivo studies are the most attractive applications of electrochemistry in
neuroscience research. The combination of spatial resolution, limits of detection, and speed place
electrochemical analysis apart from much of the other categories (Lama et al., 2012).
Additionally, the cost and maintenance of electrochemistry instrumentation is a fraction of what
it costs to purchase and maintain imaging equipment.
2.3.1 Fast Scan Cyclic Voltammetry
Fast scan cyclic voltammetry (FSCV) stands out as both a historic and modern
methodology for neurochemical measurements. When coupled with a carbon fiber
microelectrode, FSCV exhibits the high spatial resolution, speed, sensitivity, and selectivity
required for neurochemical measurements (Lama et al., 2012). Like classical cyclic voltammetry,
the FSCV technique involves an application of a potential at an electrode surface in the form of a
triangular wave. In FSCV, however, the potential is applied at a high scan rate. Rapid
measurements can be recorded under these high scan rates over the course of milliseconds,
allowing for high temporal resolution. Repeats of these waveforms deliver kinetic information
regarding the concentration of these electroactive species (Roberts & Sombers, 2018). However,
the current produced solely from the electrode is typically greater than the physiological
presence of the neurochemicals. To overcome this challenge, background subtraction is used to
measure the changes of a FSCV signal from a reference point (Rodeberg et al., 2017).
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FSCV has been widely used to study the dopamine system. Dopamine, like other
monoamine neurotransmitters in the brain, is electroactive. Following the forward scan of the
applied potential, typically from -0.4V to 1.3V, dopamine is oxidized to form dopamine-oquinone, whereas in the reverse scan dopamine-o-quinone is reduced back to dopamine (Figure
6). The flow of electrical charge involved in the redox reaction is measured as current, which is
proportional to the concentration of the analyte, according to Faraday’s law of electrolysis.

Figure 6. Redox reaction of dopamine. Dopamine oxidizes to dopamine-o-quinone at a
characteristic electrode potential, whereas dopamine-o-quinone reduces back to dopamine at a
suitable reduction potential.
Data collection in FSCV can be represented in three different forms: a cyclic
voltammogram, a current versus time plot, and a pseudo-color plot (Figure 7). Voltammograms
are obtained from the change in potential through the rapid application of waveforms. The redox
activity of the analyte acts as the signature to selectively identify the analyte of interest. Time
plots are the product of Michaelis-Menten kinetics equations. The pseudo-color plot marks the
incorporation of the previous two plots. Current stands out as the colored component
representative of the z-axis of the plot, with time and the applied electrode voltage designated as
x and y-axis, respectively.
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Figure 7. Types of data collected from FSCV measurements. (A) Pseudo-color plot displaying
the applied potential over time; green indicates oxidation, black/blue denotes reduction. (B)
cyclic voltammogram characterizing the specific redox of dopamine: oxidation peak at
approximately +0.6 V and the reduction peak at -0.3 V. (C) Current vs time plot, indicating the
redox activity at the electrode surface. Currents can later be converted into concentration terms
via Faraday’s Law.
2.3.2 Advantages of Fast Scan
Cyclic Voltammetry
The high temporal resolution of FSCV further separates it from other analytical
techniques used in neurochemical measurements. FSCV also exhibits the capability of a fast
sampling rate, covering a milliseconds range (Lama et al., 2012). This action is achieved through
the delivery of a negative waveform potential, yielding an increase in the hold of dopamine
concentrations. By promoting this holding potential, more absorption can occur along the carbon
fiber electrode, providing a greater selectivity when compared to alternative analytical methods.
In vivo studies are another realm appealing to the utilization of FSCV (Figure 8). Through the
implantation of electrodes in animal subjects, voltametric recordings can be made in real-time.
The ability to collect data within the native environment of a subject yields valuable evidence
regarding the mechanisms involved in neurotransmitter release and uptake events (Robinson et
al., 2003).
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Figure 8. Stereotaxis apparatus example. (A) Arms contain measurement knobs (in mm) which
direct probe placement into the subject. (B) Nose bar which fits over the mouth and nose to
secure the subject and orient head tilt. (C) Ear bars also secure the subject and orient
measurements for electrode implantation. (D) Alternate view of stereotaxis arm, which can hold
electrodes for subject implantation.

The space within the synapse is small, between 10 to 100 nm. Carbon fiber has emerged
as the material of choice due to its small size, ease of electrode fabrication, and relatively inert
chemical properties (Figure 9). The use of carbon fiber electrodes allows for measurements
within the micrometer range and is associated with minimal tissue damage (Abdalla et al., 2017).
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Figure 9. Electrode fabrication process. (A) Carbon fiber is aspirated through borosilicated glass
using vacuum suction. (B) Glass capillaries are pulled by heating and melting the glass to form a
seal with the carbon fiber. (C) The pulled electrode is inspected for quality of the fiber and cut to
between 50 and 100 microns under a microscope. (D) The electrode is connected with a wire and
pin, reinforced with heat-shrink, and can now be connected to the potentiostat.

FSCV can also be used with brain slices (Figure 10), with the primary advantage being
the ability to provide presynaptic control over dopamine release. The technique also limits the
effects from dopaminergic cell bodies through artificial stimulation by using a stim electrode,
which allows for the focus to be on the presynaptic dynamics (Maina et al., 2012). The addition
of pharmacological agents is also more convenient under slice FSCV. Under in vivo conditions,
applied agents require sufficient clearance time between recording measurements.
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Figure 10. Example of in vitro FSCV set-up where brain slices are stimulated within the slice
well. Electrodes are positioned with micromanipulators and the tissue is constantly perfused with
oxygenated artificial cerebrospinal fluid (aCSF).
Slice FSCV is ultimately limited by the effects of dissection of the tissue sample. Due to
the separation of large sections of the tissue most of the complex connections of the neural
pathway have been severed. Connections and innervations from different brain regions are made
inaccessible under these experimental conditions, keeping the utility narrow.
2.3.3 Innovations in Fast Scan
Cyclic Voltammetry
Electrode modifications is one area of improving and innovating the performance of
FSCV. Changes to the carbon fiber enhances the redox activity, allowing for a more extensive
detection capability. Carbon fiber electrodes can be improved with nanotube modifications (C.
Yang et al., 2016), or through coating the surface, such as treating the surface with 4sulfobenzene (Hermans et al., 2006).
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Paired pulse voltammetry (PPV) further advances the detection capabilities of FSCV
through the addition of a secondary waveform. Instead of managing singular waveforms, paired
pulse voltammetry deals with the procurement of binary (primary and secondary) waveforms;
processed with a timed gap between each wave form. Both waveforms are collected according to
their applied potential, just as in standard FSCV (Oh et al., 2015). Analytes and metabolites are
differentiated according to their respective scan repetition time, sweep rate, and peak voltage of
the triangular waveform (Jang et al., 2012).
Alternatively, neurochemical release can also be stimulated through light instead of
electrical potentials. Optogenetics induces neurotransmission by incorporating photosensitive
proteins into the host nerve of interest by genetic engineering. Light activation provides the
advantage of increasing selectivity to only the neurons expressing the opsin proteins (Guru et al.,
2015). Optogenetics, however, exhibits analogous information to electrically stimulated FSCV.
Additionally, the instrumentation costs of optogenetics are exorbitantly more expensive when
compared with the more cost effective conventional FSCV.
2.3.4 Immunoassays
Immunoassays like Western Blot and flow cytometry are also useful in detecting and
measuring specific receptor proteins. Western Blot is a common technique used in the isolation
and quantification of proteins. Homogenized tissue samples can have their proteins segregated
by mass and charge through the utilization of size proportioned gel and electrophoresis (Taylor
& Posch, 2014). Proteins appear in the gel as bands according to their exclusionary separation.
The identity of the proteins is revealed by the specialized targeting with antibody-antigen
staining. Concentration is measured through the strength in absorbance presented in the sample.
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Dopamine receptors have previously been identified and quantified using Western Blot analysis
(Levey et al., 1993).
A multitude of different proteins can be contained within each of the blot’s bands.
However, the combination of protein separation and immunoblotting act as the key advantages of
this method. The expression of the tagged immunostaining complex maintains the specificity to
identify the protein of interest. Western Blot also carries a low-cost instrumentation with an ease
of repeatability for comparative analysis, which is attributed to the technique’s enduring
laboratory usage.
Immunocytochemistry offers a complimentary approach to protein analysis through the
examination of the tissue’s structural environment. This methodology integrates the specific
protein areas via targeted antibodies in order to identify the precise analyte of interest and
imaged using fluorescent or confocal microscopy (Mize et al., 1988; Nabors et al., 1988). Effects
on protein receptors can be directly visualized and their localization as well as distribution can be
compared to view the changes inflicted by the experimental parameters.
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CHAPTER 3
MATERIALS AND METHODS
The methods described here encompass the use of biochemical assays and neurochemical
techniques to characterize auditory brain function. All the experimental protocols involving
animals used in this research were approved by the Institutional Animal Care and Use
Committee (IACUC) of the University of Northern Colorado.
3.1 Chemicals
The reagents used to prepare the artificial cerebrospinal fluid (aCSF) for slice
voltammetry were purchased from Fisher Scientific Co. (Fairelawn, NJ) and Sigma Aldrich (St.
Louis, MO). Antibodies were procured from Alomone Laboratories (Jerusalem, Israel).
3.2 Animal Subjects
Thirty-two adult Sprague Dawley rats were used in this research project. This rat strain
has been used extensively in previous work regarding the inferior colliculus. In rats, the inferior
colliculus is larger and more easily characterized.
3.3 Noise Exposure Chamber
The noise chamber used in this work was fabricated in-house with the following
dimensions: 36” wide x 30” long x 25.5” tall (Figure 11A). The interior of the chamber was lined
with sound dampening foam to reduce the influence of the surrounding environmental noise
(Figure 11B). Speakers are placed in an even square arrangement at 16” at each corner. The
interior was lined with sound absorbing foam. In the ceiling of the chamber, four TW44 speakers
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(Parts Express, Springboro, OH) were embedded in an evenly spaced manner and wired
according to a combined series/parallel schematic (Figure 11 C).

Figure 11. Noise exposure chamber. (A) Exterior of the chamber. (B) Interior of the chamber
lined with sound dampening foam. (C) Schematic of series/parallel wiring arrangement of the
sound exposure booth’s tweeters providing a total impedance of 4 ohms.
The speakers are connected to a multicomponent sound amplification system as follows;
a Beringer NX-4000 amplifier (Parts Express, Springboro, OH), and a computer system to
control and deliver the appropriate tones/frequencies. The speakers to the amp were connected
via crimp terminals, alligator clips, and Speak-On respectively. The computer interface was
connected with the amplifier according to a 1/4” to standard audio jack which can be plugged
into the amplifier and computer, respectively. Sound delivered into the system was controlled
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using Daqarta v10.5.2 software (Interstellar Research, Ann Arbor, MI). Noise exposures were set
to 10 kHz at 118 dB sound pressure level (SPL) at 1/3 octave band.
3.3.1 Calibration of Noise
Exposure Chamber
The sound chamber was calibrated by determining the average distance between the
ceiling mounted speakers and the animal subject’s ears. A Radio Shack digital sound meter (Fort
Worth, TX) was used to measure the distribution of the sound cone from the speakers within
three dB. The meter was also adjusted at a variety of different angles analogous to the location of
the animal subject’s ears and positions to ensure the appropriate sound (3 dB) overlap and
evaluated any contributions in the sound box to random noise.
3.4 Fast Scan Cyclic Voltammetry System
3.4.1 Electrode Fabrication
Carbon fiber microelectrodes were made using the following steps. First, the carbon fiber
(Goodfellow, Huntingdon, England) was separated into single strands and aspirated through a
borosilicated glass capillary tube (A-M Systems, Sequim, WA) via vacuum suction. The
capillary tube was then pulled using a Narishige PE-22 puller (Tokyo, Japan). This process
sealed the glass capillary-carbon fiber interface. The exposed carbon fiber was then cut to an
appropriate length using a microscope (Olympus, Center Valley, PA), according to a
microscopic reticule between 50 to 100 μm. Next, the electrode was pinned and connected with a
metal wire that had been coated with carbon paint (Alfa Aesar, Tewksbury, MA) to establish an
electrical connection between the wire and the aspirated carbon fiber. Heat shrink was then
applied at each end of the gap junctions where the connecting wire and glass capillary meet, as
well as where the wire was soldered to the interface pin, to reduce noise and to reinforce the
structural integrity of the microelectrode (Figure 12).
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Figure 12. Progression of electrode fabrication. (A) Schematic of carbon fiber aspiration, pulling
and cutting the fiber to an optimal length. (B) Schematic of completed carbon fiber
microelectrode. (C) Example of completed carbon fiber microelectrode.
3.4.2 Electrode Conditioning and
Calibration
The process of conditioning the electrode was achieved through the continuous cycling of
the waveform on the electrode. A higher cycling frequency was used to etch the electrode surface
thereby increasing the sensitivity to electroactive species under this potential window. This step,
in turn, improves the electrode’s capability towards the electroactive species at the applied
waveform. A 60 Hz frequency was applied to achieve this conditioning for approximately 5
minutes, or until the oscilloscope signal was stabilized, where a smooth charge to discharge
indicates a good electrode (Figure 13).

Figure 13. Oscilloscope of a CFME cycling at 60 Hz. (A) Initial electrode status is resistive due
to the flattened peak. (B) Electrode displays the shifting discharge profile. (C) Electrode
maintains a stable charge to discharge peak, indicative of a good electrode.
Next, the calibrated electrode was characterized by determining its sensitivity and
effectiveness as well the reproducibility of the signals. A three port T-flow cell was used to make
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these measurements. An Ag/AgCl reference electrode was sealed in the center of the cell. The
first of the side ports being used to introduce a continuously perfusing modified cerebrospinal
fluid via a syringe pump at a flow rate of approximately 2 mL/min. The calibration buffer was a
modified form of the artificial cerebrospinal fluid used in slice voltammetry. The buffer was
composed of 126 mM NaCl, 2.5 mM KCl, 2.4 mM CaCl2, 1.2 mM MgCl, 1.2 mM Na3PO4, 25
mM NaHCO3 set to a pH = 7.4, as described by (Maina et al., 2012). The second port was used
to manually inject about 0.5 to 1.0 mL of a prepared 500nM dopamine standard through a
syringe into the cell. The dopamine was detected at the electrode surface according to the change
in the peak current measured (Figure 14). This process was repeated several times in order to
obtain an average peak current related to the consistent concentration of the dopamine injected.
This procedure was performed before (pre-calibration) and after (post-calibration) data
acquisition from brain slices. The calibration factor was determined from the analysis of the
electrode responses.

Figure 14. Schematic of the flow cell FSCV set-up for electrode calibration and characterization.
Electrodes are characterized through the utilization and comparison between different
standards. Dopamine is recorded first as it is the analyte of interest. Next, ascorbic acid is
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analyzed, as it is the chief interferant in biological measurements. The unique waveform
signature generated acts as the primary differentiation between both standards. Ascorbic acid
produces a single oxidation peak at approximately +0.8 V, where dopamine yields one oxidation
peak at +0.6 V and one reduction peak at -0.25 V. The distinctive shape of each chemical
supplies the details to gauge the performance of the selected electrode.
3.4.3 Slice Fast Scan Cyclic
Voltammetry Data
Collection
Prepared prior to the extraction of rat brain tissue, sucrose aCSF was prepared and used
for vibratome sectioning of brain slices. Composition of the sucrose aCSF was 30 mM NaCl, 4.5
mM KCl, 1 mM MgCl2 26 mM NaHCO3, 1.2 mM NaH2PO4, 10 mM D-glucose, 180 mM
sucrose. The buffer was then oxygenated with carbogen gas (95% O2/ 5% CO2) for
approximately 15 minutes before refrigerating it. The buffer was good for up to a week under
these conditions. Animal subjects were sacrificed using an induction chamber (Harvard
Apparatus, Holliston, MA) via CO2 asphyxiation. Next, the brain was quickly removed and
placed immediately into the chilled sucrose aCSF.
The extracted brain tissue was mounted with super glue onto a removable stage on a 1500
series vibratome (San Macros, CA). The cold sucrose aCSF was used to fill a tray surrounding
the sample tissue to keep the brain viable throughout sectioning. Coronal slices were taken from
the brain tissue at 400 micron thickness to fully encompass the region of interest (inferior
colliculus). The slices were then transferred into the running buffer, where they were left to
equilibrate in bubbling carbogen gas for one hour.
A brain slice was placed in an automate scientific slice chamber (Berkeley, CA) where a
recording aCSF buffer composed of 126 mM NaCl, 2.5 mM KCl, 2.4 mM CaCl2, 1.2 mM
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MgCl2, 25 mM NaHCO3, 1.2 mM NaH2PO4, 11 mM D-glucose, 0.4 mM ascorbic acid; was
being continuously perfused with carbogen at 2 mL/min by a Watson-Marlow peristaltic pump
(Wilmington, MA). The recording chamber was also held at a 37℃ temperature using a
temperature controller (Automate Scientific, Berkley, CA).
Dopamine release was induced from the brain region of interest using electrical
stimulation using a positive monophasic polarity with a frequency of 60, an amplitude of 4.5, and
a pulse length of 4 ms. The electrical stimulation was generated by a Neurolog stimulation
generator (Herfordshire, UK) and administered onto the brain slice through a stimulating
electrode (Plastics One Inc, Roanoke, VA). Detection and characterization of dopamine release
and uptake was achieved through the application of a triangular waveform potential at the carbon
fiber working electrode surface. The electrical potentials span from -0.4 V to +1.3 V and back to
-0.4 V at a scan rate of 400 Vs-1 every 100 ms with a frequency of 10 Hz, over a recording period
of 10 seconds. An Ag/AgCl electrode was used as a reference electrode embedded in the
recording chamber and connected to the white reference junction on the headstage. Once a stable
signal was acquired, stimulations were then applied every 5 minutes to provide the neurons time
to replenish the neurochemical stores within the synaptic cleft. Pharmacological manipulations of
the brain slices were done using to determine or confirm the identity of the neurochemical
present in the brain region. The main hardware components consisted of an integrated national
instruments PCIe-6363 multifunction I/O device (Austin, TX) connected to a Pine Research
Waveneuro potentiostat (Durham, NC). Data was generated by HDCV software (Chapel Hill,
NC). A variety of computer software was incorporated to gather and analyze the data from this
research. High Definition Cyclic Voltammetry (HDCV) software from the University of North
Carolina (Chapel Hill, NC) and Wild Cat Cyclic Voltammetry software (WCCV)from Dr. Hein’s
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lab at the University of Arizona (Tucson, AZ) were used in coordination with the potentiostat
systems to collect and analyze the electrochemical data. The entire system was shielded from
electrical noise using a Faraday cage (Automate Scientific, Berkeley, CA).
3.4.4. Pharmacological
Manipulations
Brain slices were treated with pharmacological agents to assist in identifying the source
of the peaks observed during FSCV. Tetrabenazine (TBZ), a Vmat antagonist which reduces
monoamine release, was prepared from a stock solution dissolved in ethanol before being further
diluted. A 10 μM working dose was prepared from the stock solution and diluted in the aCSF
running buffer. 50 μM αMPT, a tyrosine hydroxylase inhibitor, was prepared in a typical 0.9%
saline solution.
Once the FSCV signal was stable, the running buffer solution was replaced with a buffer
solution containing one, or a combination of, the previously mentioned pharmacological agents.
Following perfusion, data collections were continued according to 5-minute stimulus intervals
for 30 minutes per a drug concentration. The dosage was increased every 30 minutes until the
last dose.
3.5 Immunocytochemistry
Changes in dopamine receptor protein localization and distributions in the inferior
colliculus of the brain were characterized by immunocytochemistry (ICC).
3.5.1 Tissue Preparation
and Staining
Control and sound exposed subjects were euthanized using carbon dioxide asphyxiation,
the brain was extracted and quickly frozen by wrapping it in parafilm then burying the tissue in
dry ice until thoroughly frozen (approximately 5-10 minutes). The brain was then oriented and
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mounted using Optimal Cutting Temperature (O.C.T) medium rostral side down. A
Thermofisher (Fairelawn, NJ) cryostat maintained at low temperature (-20℃) was used to
section the brain tissue into 40 micron sections and mounted on poly-L-lysine coated positively
charged slides.
Prior to antibody staining, the slides were first post-fixed in a solution of 4%
paraformaldehyde in a 50/50 mix of absolute ethanol and water for 2 minutes. Slides were then
transferred into a light protected moisture chamber (Newcomer Supply, Middleton, WI) and
treated with a 3% donkey blocking serum (Jackson Immuno Research, West Grove, PA). The
donkey serum was prepared in 1x PBS with 0.5% Triton X-100 (Sigma Aldrich, St. Louis, MO).
The blocking serum is removed without rinsing the slides. Next, the slides are treated with
dopamine receptor (DRD2) primary antibody (Alomone Labs, Jerusalem, Israel) at a 1:100
dilution prepared with 1% donkey serum, 0.3% Triton X-100. The slides were covered with a
coverslip and sealed with rubber cement; then left to incubate in the primary antibody for 48
hours in the refrigerator. Following incubation, the rubber cement was peeled off and the slides
were thoroughly washed with 1x PBS five times, or approximately 10 minutes. The secondary
antibody was prepared at a 1:500 dilution in 1% donkey serum and 0.3% Triton X-100 and
incubated for one hour at room temperature. After treatment with the secondary antibody, slides
were again washed with 1x PBS for another 10 minutes, or five times. Then slides were mounted
with Fluoromount (Southern Biotech, Birmingham, AL) and coverslipped. Following the
antibody incubation, slides were visualized with a fluorescence confocal microscope
(Oberkochen, Germany), and representative images were taken to identify the anatomical areas
of interest, and dopamine receptors were analyzed.
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3.6. Data Analysis
Fast Scan Cyclic Voltammetry (FSCV) analysis was performed using the High Definition
Cyclic Voltammetry (HDCV) Analysis software. Pre-calibrations were gathered before the
experiment, performed in quadruplicate, then used to generate a calibration factor by dividing the
monoamine standard concentration by the average peak current. The standards were captured,
which included their cyclic voltammogram, and was used to train the software in coordination
with the calibration factor to match the same corresponding voltammogram pattern that presents
in the data file. The training set converted any matching signal from the standards and translated
it into a current versus time plot. Signals not determined from the training set, such as artificial
stimulation artifacts or interfering analytes, were not represented. Peak current signals were
automatically converted to concentration which could then be extracted and examined
statistically.
Immunocytochemistry quantifications were performed using ImageJ software (Bethesda,
MD). Slide images were cropped to only include the brain region of interest. The image was then
converted to grayscale in order to maximize the contrast between pixel signals. Any background
from the staining was corrected by shifting the scale to auto max and applying a dark
background. Only representative pixels will then appear, which are associated with positive
receptor staining. The software provided the appropriate count of the pixels that were present.

33

CHAPTER 4
RESULTS
4.1 Fast Scan Cyclic Voltammetry System
Design and Validation
Fast scan cyclic voltammetry stands as an elegant tool for detecting and quantifying
neurochemicals within a complicated biological environment. Due to the complications inherent
in taking these measurements, the FSCV system must be adequately calibrated and validated.
Herein, dopamine and potential interfering agents, such as ascorbic acid were measured with a
flow-cell based FSCV.
4.1.1 Calibration with Dopamine
Dopamine is the primary analyte in this project. A series of dopamine standards were
prepared in the calibration artificial cerebrospinal fluid outlined under the methods section 3.4.3.
Measurements were gathered via flow cell injection and application of electrical potential in a
triangular waveform extending from -0.4 to +1.3 V and back to -0.4 V at a scan rate of 400 V/s
at a carbon fiber microelectrode surface. The flow cell measurements provided cyclic
voltammograms of the dopamine standards from 100 to 700 nM in 100 nM increments (Figure
15 A). Dopamine is known to oxidize at ~ 0.6 V and reduces at ~ -0.2 V, as indicated by the
figure 16A. The shape of the voltammogram also provides a confirmation of the analyte. At
increasing concentration, the peak current demonstrates an equivalent increase. To examine the
full extent of the linear relationship between the peak current and concentration, the peak current
was plotted against the standard dopamine concentration (Figure 15 B).
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Figure 15. Dopamine calibration using flow cell FSCV. (A) Dopamine cyclic voltammogram of
standards relating increasing peak current with increasing concentration. (B) Dopamine
calibration curve with linear regression and correlation applied.
A linear regression of the relationship between dopamine peak current and the
concentration of the flow cell injected standards was performed. The equation of the line was
obtained to be y = 0.2219x – 1.623 with coefficient of determination, R2 of 0.989, suggesting a
good linear correlation between the instrumental response and concentration (Figure 15 B).
Based on the data derived from the calibration curve the limit of detection (𝐿𝑂𝐷 = 3.3 ∗
𝑠𝑙𝑜𝑝𝑒
𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛

𝑠𝑙𝑜𝑝𝑒

) and limit of quantification (𝐿𝑂𝑄 = 10 ∗ 𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛) can be calculated

as 0.2 nM and 0.5 nM, respectively.
4.1.2 Ascorbic Acid Calibration
Ascorbic acid is a naturally occurring antioxidant that can also be found in significant
quantities in the brain, commonly presenting as the chief interfering analyte in neurological
measurements; accounting for and characterizing the presence of ascorbic acid becomes
essential. Ascorbic acid demonstrates a single oxidation peak at approximately 0.6 V and so a
triangular waveform was applied, ranging from -1.0 to +0.8 V, to encompass the full
electroactive range of the analyte. Like the dopamine calibrations, the ascorbic acid calibration
was performed through a flow cell injection of 1 to 10 mM ascorbic acid standard with 1 mM
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increments. An overlay of the voltammograms were generated according to the increasing
concentrations (Figure 16 A).

Figure 16. Ascorbic acid calibration by flow cell FSCV. (A) Cyclic voltammogram overlay of
ascorbic acid standards denoting changes in peak current with increasing standard concentration.
(B) Ascorbic acid calibration curve with linear regression and correlation analysis applied.
The peak current generated from the flow cell injections were plotted against the
concentration of the standards. A linear regression analysis was performed. The equation of the
line was obtained to be 𝑦 = 103.43𝑥 + 624.62 with coefficient of determination, R2 of 0.9849,
suggesting a good linear correlation between the instrumental response and concentration (Figure
16 B). Based upon the data derived from the calibration curve the limit of detection (𝐿𝑂𝐷 =
𝑠𝑙𝑜𝑝𝑒

𝑠𝑙𝑜𝑝𝑒

3.3 ∗ 𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛) and quantification (𝐿𝑂𝑄 = 10 ∗ 𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛) were determined to
be 1.2 nM and 4.8 nM, respectively.
4.1.3 Dopamine/Norepinephrine
Calibrations
Aside from dopamine and ascorbic acid, norepinephrine displays electroactivity along the
same waveform potential. Additionally, stimulation events may produce the release of a
multitude of different neurochemicals simultaneously. Dopamine and norepinephrine belong to
the monoamine classification and, as such, are synthesized through the same process with
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norepinephrine being downstream of dopamine. A mixture of dopamine and norepinephrine was
examined to see if the system could discriminate between the two monoamines. The same
calibration procedure for dopamine, including the waveform parameters for was employed for
the combination mixture. The dopamine-norepinephrine mixture had concentrations ranging
from 200 to 1000 nM by 200 nM increments. An overlay of the voltammograms were produced
(Figure 17 A) to demonstrate the different shape and distributions of the redox potentials for the
combination analytes. Dopamine’s peak oxidation remained at ~ +0.6V and was utilized in the
generation of the calibration curve. The oxidation peak for norepinephrine appears at ~ +0.2V.

Figure 17. Flow cell FSCV of dopamine and norepinephrine in mixture. (A) Voltammogram
overlay of dopamine and norepinephrine mixture indicating an increasing trend between peak
current for dopamine and the concentration. (B) Calibration curve of dopamine peak current
versus the concentration of the dopamine-norepinephrine standards.
The peak oxidation current for dopamine from the flow cell measurements of the mixture
was plotted against the concentrations of the mixture (Figure 17 B). A linear regression of the
relationship between the combinations of both dopamine and norepinephrine peak current and
concentration of the flow cell injected standards was performed. The equation of the line was
obtained to be 𝑦 = 0.0594𝑥 + 19.343 with a coefficient of determination, R2 of 0.9842,
suggesting a good linear correlation, indicating a robustness of the dopamine signal in the
presence of another monoamine (Figure 17 B).

37
4.2 Fast Scan Cyclic Voltammetry Analysis
in Brain Slices
The optimum parameters established with the flow cell FSCV were utilized in the slice
FSCV. The data obtained were in the form of pseudo color plots, current vs time plots, and cyclic
voltammograms.
4.2.1 Measuring Dopamine in
the Inferior Colliculus
A typical cyclic voltammogram for dopamine has a single oxidation peak at ~ +0.6 V and
reduction peak at ~ -0.2 V, corresponding to the green and blue colors, respectively in the pseudo
color plot (Figure 18 C & D). However, the data obtained from the slice FSCV measurement
from the inferior colliculus resulted in a voltammogram with two distinct oxidation peaks at ~ 0.2 and +1.0 V and one reduction peak at +0.15 V. The corresponding pseudo color plot (Figure
18 A & B) also reflects the emergence of both oxidation peaks. By comparing the slice FSCV
data with the expected voltammogram (Figure 18 A & B versus C&D), it is obvious that two
electroactive species are being detected simultaneously from the slice measurement.
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Figure 18. Sample of slice FSCV color plots and voltammograms. (A) Color plot from control
subject, indicating two separate oxidation peaks in green. (B) Corresponding cyclic
voltammogram displaying the two oxidation peaks (1 & 2). (C) Example of an expected color
plot for dopamine, with (D) corresponding cyclic voltammogram.
Since the waveform applied can initiate redox reactions from other monoamines, the
most likely suspect of the secondary peak is another monoamine. Norepinephrine has the same
redox window as dopamine and could be a reasonable candidate for the secondary signal. The
FSCV software can generate training sets from flow cell injected standards to produce a signal
that can be useful for identification purposes. The dopamine and norepinephrine mixture was
analyzed through the flow injection system and a training set was generated through a K-Matrix
algorithm (Figure 19 A). A comparison of the K-Matrix training set with the corresponding
pseudo color plot for the flow cell injected dopamine-norepinephrine standard versus the slice
FSCV data suggests simultaneous detection of the two monoamines in the slice measurement
(Figure 19).

39

Figure 19. Comparison of the data from flow cell injected dopamine-norepinephrine standards
with the slice FSCV data. (A) K-Matrix analysis of the predicted cyclic voltammogram for the
dopamine-norepinephrine standard solution. (B) Cyclic voltammogram for the slice FSCV
demonstrating similarity with the K-Matrix prediction. (C) Flow cell-produced pseudo color plot
for dopamine-norepinephrine standard solution. (D) Pseudo color plot for the slice FSCV.
Peak current can be converted into concentration through the application of a calibration
factor. This conversion was determined through pre-calibration measures of several runs of the
neurochemical standard, either dopamine or norepinephrine, and then calculating the calibration
factor in terms of nA/nM. Thus, the current vs time traces can be converted into a concentration
vs time trace. The two suspected monoamine peaks plotted for both current vs time (Figure 20
A) and concentration vs time (Figure 20 B). Each of the peaks between were distinct and
independent of the other, suggesting that they are not just artifact signals.
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Figure 20. Comparisons of peak 1 and 2 neurotransmission events in a control subject. (A)
Current vs time trace between peak 1 and 2. (B) Concentration vs time trace between peak 1 and
2.
Peak 1 was further examined with the analysis software using Fourier transformations to
isolate the signal from peak 2. This transformation was possible in part due to the peak 1 having
a higher concentration than peak 2. Peak 2 was filtered out using the transformation and was
absent in the newly generated color plot (Figure 21 A). Further analysis of the transformed
voltammogram reveals a close resemblance to the cyclic voltammogram of dopamine standard,
with a reduction peak appearing at -0.25 V and an oxidation peak slightly right shifted at +1.0 V
(Figure 21 B). Additional attempts at transforming the lower peak could not be achieved without
dropping the total signal.

Figure 21. Fourier Transformation of the slice FSCV data. (A) Pseudo color plot of Fourier
transformed data depicting the now singular oxidation peak. (B) Cyclic voltammogram of
Fourier transformed data displaying a more traditional dopamine CV.
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4.2.2 Pharmacological Verification
of the Identity of the Slice Fast
Scan Cyclic Voltammetry Data
The analysis presented by the K-Matrix and the Fourier transformations provides the first
supporting evidence towards identifying two signals in the FSCV data. Pharmacological agents
can be used to selectively target the specific sections of the neurochemical pathway through
either activation or inhibition of specific receptors, or proteins that could aid in the identification
of the signals.
4.2.2.1 Tetrabenazine
Tetrabenazine (TBZ) is a hexahydro-dimethoxy-benzoquinolizine derivative that operates
as a monoamine, depleting drug by blocking the vesicular monoamine transporter 2 (VMAT2),
which is responsible for packing monoamines, such as dopamine and norepinephrine into their
respective vesicles (Yero & Rey, 2008). Varying concentrations of TBZ was added to the
oxygenated aCSF running buffer perfusing through the slice FSCV recording chamber after
obtaining a stable signal from the brain slice. The effect of each dose of TBZ on the signal was
measured every 5 minutes for 30 minutes.

Figure 22. Effect of TBZ on the slice two FSCV signals measured from the inferior colliculus.
(A) Peak 1 concentration decreases with increasing dose of TBZ perfused through the recording
chamber. (B) Peak 2 concentration also decreases with increasing dose of TBZ. The data
confirms the two peaks to be monoamines.
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The peak current from the current vs time trace was converted to concentration using the
pre-calibration factors for both monoamine standards. Each peak demonstrated a decrease in the
concentration of the release event with increasing concentration of tetrabenazine, thus suggesting
the two peaks are monoamines (Figure 22). The effectiveness of the drug can be determined
through examining the resulting drug influence. Since the drug operates through an inhibitory
mechanism, the drug’s efficacy is described as an IC50. Which means the concentration at which
the drug inhibited 50% of the response. The IC50 was determined from a plot of the logarithmic
transformation of the concentrations of tetrabenazine versus the normalized FSCV signal. The
concentration of tetrabenazine that reduced the release signal for peak 1 in the inferior colliculus
by 50% was calculated to 6.62 μM (Figure 23 A) with a correlation coefficient of 0.9827. The
amount of tetrabenazine needed to reduce the release signal for peak 2 by 50% was determined
to be 36.5 μM (Figure 23 B) and a correlation coefficient of 0.6400.

Figure 23. Dose response curve depicting the IC50 values for TBZ for peak 1 and peak 2 signals
recorded from the inferior colliculus. (A) IC50 for peak 1 dose respond curve relating an
effective concentration of TBZ at 6.62 μM. (B) IC50 of peak 2 relating the effective
concentration of TBZ at 36.5 μM.
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4.2.2.2 Quinpirole
The current pharmacological experiments have demonstrated the two peaks to be signals
from monoamine neurotransmission, however, to further identify the peaks another round of
pharmacological studies was performed. Quinpirole operates as a dopamine D2/D3 receptor
agonist which, in turn, triggers the inhibitory effects of the dopamine autoreceptors (Eagle et al.,
2014). Thus, perfusions with quinpirole are expected to decrease the concentration of dopamine
release, while leaving the signals from monoamines, like norepinephrine, unaffected.
Quinpirole perfusion was performed using the same procedure as TBZ. The drug
perfusion began following a stable baseline signal starting with a dose of 0.001 μM and
increased by one order of magnitude over the course of 30 minutes of perfusion before ending at
a final quinpirole concentration of 10 μM; with voltametric recordings being taken every 5
minutes for 30 minute per dose of the drug. The stimulated current was converted into
concentration according to the procedure as already described.

Figure 24. Effect of quinpirole on monoamine release. (A) Concentration vs time traces for peak
1 demonstrating decrease release per increasing quinpirole concentration. (B) Peak 2 signal was
not significantly impacted by the varying dose of quinpirole.
The concentration of peak 1 signal displayed a clear and consistent decrease across
increasing quinpirole concentrations (Figure 24 A). The effects of quinpirole on peak 2
concentrations only displayed minor fluctuations but remained otherwise unchanged (Figure 24
B).
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An IC50 analysis was performed to assess the effective inhibitory concentration for both
peaks. The effective inhibitory concentration of quinpirole for reducing the peak concentration of
peak 1 was 9.65 x10-3 μM (Figure 25 A). The correlation coefficient was 0.9703. The IC50 for
the peak 2 control groups were tabulated to be 2.47 x 1030 μM (Figure 25 B). The correlation
coefficient for both control groups was 0.0006.

Figure 25. Dose response curve for quinpirole’s action on the two monoamines. (A) Analyzing
quinpirole’s effect on the release concentration of peak 1. (B) Quinpirole’s effect on the release
concentration of peak 2.
4.2.2.3 Sulpiride
Sulpiride is a selective antagonist for dopamine D2 receptors that is also reported to block
D3 and D4 receptors (Caley & Weber, 1995). While quinpirole operates to reduce the overall
output of dopamine from target neurons, sulpiride acts much in the opposite fashion. Since D2
receptors are inhibitory, blocking their activation leaves more dopamine within the synapse,
ultimately leaving an overall net increase in dopamine release. Sulpiride is often included in
experiments that are treated first with quinpirole to restore functionality of the receptor following
the activations from quinpirole.
Sulpiride perfusions were performed following the previous quinpirole experiments
outlined in section 4.3.3. After the final quinpirole concentration had been perfused, the running
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aCSF buffer was replaced with fresh running buffer for 10 minutes to clear the lines, then a new
solution with 0.001 μM sulpiride was perfused over the brain slice in the recording chamber for
30 minutes. The sulpiride concentration was increased, replicating the same doses as the
quinpirole experiment. The sulpiride dose was perfused for 30 minutes with voltammetry
recordings being taken every 5 minutes.
Peak 1 concentration was either very low or near 0 following the quinpirole drug
perfusions. Initiating cumulative doses of sulpiride demonstrated increases in peak 1
concentrations (Figure 26 A). The effect of sulpiride on peak 2 displayed minor fluctuations the
concentration of the signal (Figure 26 B).

Figure 26. Effect of sulpiride on monoamine release. (A) Peak 1 concentration increases with
increasing sulpiride dose. (B) Impact of sulpiride perfusion on the concentration of peak 2.
An EC50 analysis was performed to assess the effective concentration to which 50%
response was elicited by the drug. The effective concentration of sulpiride on peak 1
concentration was 0.989 μM (Figure 27 A). The correlation coefficient for the peak 1 was
0.7956. The EC50 for peak 2 was 0.264 μM (Figure 27 B), with a corresponding correlation
coefficient of 0.2651.
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Figure 27. Sulpiride dose response curve. (A) The effect of sulpiride on peak 1 concentration.
(B) The effect of sulpiride on peak 2 concentration.

4.2.2.4 7-Hydroxy-N,N-dipropyl-2-aminotetralin
The final pharmacological agent utilized in this study was 7-hydroxy-N,N-dipropyl-2aminotetralin (which will be referenced as 7-OH-DPAT for the remainder of the document). 7OH-DPAT acts as a selective agonist for D3 dopamine receptors. Similarly, to D2 dopamine
receptors, D3 receptors yield an inhibitory effect on dopamine neurotransmission. Additionally,
there is evidence that 7-OH-DPAT will also influence inhibition of norepinephrine release (Chu
et al., 2004). Perfusions of the drug continued with the same procedure and concentrations as the
previous pharmacological agents.
Measured monoamine release events had their peak currents converted into
concentration. Peak 1 concentration decreased over the course of the experiment with increasing
7-OH-DPAT concentrations (Figure 28 A). Peak 2 concentration had some fluctuations present,
but overall maintained a relatively consistent level throughout the course of the experiment
(Figure 28 B).
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Figure 28. Effect of 7-OH-DPAT on monoamine release. (A) Peak 1 concentration decreased
with increasing concentrations of 7-OH-DPAT. (B) Peak 2 concentration maintains a relatively
consistent value with increasing 7-OH-DPAT concentration.
7-OH-DPAT’s effectiveness was further examined using the IC50 metric. The effective
concentration of 7-OH-DPAT was determined to be 0.001 μM for peak 1 and 0.0001 μM for
peak 2 (Figure 29). The correlation coefficients for each IC50 determination was 0.9554 for peak
1 and 0.002059 for peak 2.

Figure 29. 7-OH-DPAT dose response curves. (A) Effective drug dose of 7-OH-DPAT on peak
1 was 0.001 μM. (B) Effective drug dose of 7-OH-DPAT on peak 2 was 0.0001μM.
The combined results from each of the pharmacological experiments indicate that both
peaks are monoamines. Peak 1 demonstrated extensive modulation with dopamine related
agonists and antagonists and can reliably be identified as dopamine. The second peak displayed
consistent resistance to specific dopamine targeting drugs, while also being affected by general
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monoamine inhibitors. According to the monoamine synthesis pathway, the most likely identity
of the second peak is norepinephrine.
4.2.3 Effect of Noise Exposure on
Monoamine Neurotransmission
The previous experiments have established the presence of two monoamines, dopamine,
and norepinephrine in the inferior colliculus. The effect of loud noise on the release of these
monoamines was examined. Analysis of tissues obtained from the noise exposed subjects was
conducted 24-hours after the exposure to ensure that changes measured were real and not just
transient reactions to the discomfort of the noise exposure, and to also allow adequate time for
possible compensatory response.
The two peaks observed in the control subjects persisted also in the noise exposed
subjects. By inspection, the dopamine peak for the noise exposed subjects were markedly
attenuated compared to their control, an effect that was also consistent with the norepinephrine
(Figure 30).
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Figure 30. Comparison of monoamine release in the inferior colliculus of control vs noise
exposed subjects. (B) Dopamine concentration vs time trace. (D) Norepinephrine concentration
vs time trace. (E) Exposure to loud noise decreases dopamine and norepinephrine release in the
inferior colliculus. Unpaired t-tests between control and noise exposed groups for dopamine and
norepinephrine were performed. Effects of loud noise was found to be statistically significant for
dopamine (p-value = 0.0004) and norepinephrine (p-value = 0.003).
To evaluate the significance of the effects of noise on the monoamine release in the
inferior colliculus, a set of unpaired t-tests were performed to compare the control subjects with
the noise exposed counterparts. The effects of loud noise on dopamine and norepinephrine
release was found to be statistically significant, t(10) = 5.207, p-value = 0.0004; and t(13) =
3.654, p-value = 0.003, respectively (Figure 30 E).
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Furthermore, several noise exposed subjects were left to recover for two additional days
as a confirmatory measure to determine if the effects of the noise exposure were permanent.
From an N = 3, a comparison among the monoamine groups produced an average dopamine
release concentration of 573.2 nM for the control group, 199.3 nM for the noise exposed +1 days
recovery group, and 81.80 nM for the noise exposed +3 days recovery group. The average
norepinephrine release concentration for the control group was 266.0 nM, 45.98 nM for the noise
exposed +1 days recovery group, and 31.45 nM for the noise exposed +3 days recovery group.
Each indicates that the damage in the neurotransmission incurred from the noise exposure was
long lasting (Figure 31).

Figure 31 Comparison of the effect of loud noise on monoamine neurotransmission over time.
(A) Dopamine release in control versus noise exposed groups. (B) Norepinephrine release in
control versus noise exposed groups. Noise +1: represent noise exposed subjects with 1 day
recovery time before analysis, Noise +1: represent noise exposed subjects with 3 days recovery
time before analysis.
4.2.4 Pharmacological Studies on
Noise Exposed Subjects
Similar to the control groups, pharmacological perfusions were used to further examine
the dynamics of the inferior colliculus following drug noise exposure. These experiments
followed in line with the previous pharmacological studies. While the dopamine peak was
influenced by a variety of pharmacological manipulations, norepinephrine remained unchanged
throughout and will instead be reported in Appendix B.
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Alpha-methyl-p-tyrosine (AMPT) is another pharmacological agent that operates as a
catecholamine inhibitor, specifically acting upon the monoamine synthesis pathway by inhibiting
the hydroxylation step, converting tyrosine to L-DOPA (Brogden et al., 1981). Tetrabenazine
inhibits VMAT2, which packages monoamines into their vesicles following synthesis to be
released upon action potential at the axon terminal, AMPT is often used in conjunction with
tetrabenazine to probe the synthesis process. Both drugs were included as a single cocktail to
diminish the monoamine signal more effectively. Tetrabenazine was introduced to the brain slice
alone for the first trial, then for each subsequent collection, AMPT was added and held constant
at 50 μM for the remainder of the experiment. The concentration of tetrabenazine was then
increased to 25 μM and 140 μM for each subsequent trial. Additionally, each of the previous
drug trials were repeated on noise exposed subjects and the effects of the drugs were analyzed
using their respective dose response parameters.
The combination of tetrabenazine and AMPT displayed a more definitive reduction in
overall dopamine release signal than the control experiments where tetrabenazine was used
alone. The drug combination generated an effective 50% dose response at concentration 1.302
μM (Figure 32 A). A repeat of quinpirole and sulpiride on the noise exposed groups displayed a
visually close response compared with the control experiments. The effective dose concentration
was calculated as 0.01328 μM for quinpirole (Figure 32 B) and 0.1618 μM for sulpiride (Figure
32 C). 7-OH-DPAT appeared slightly different than the control counterpart, delivering an
effective dose concentration of 0.02298 μM (Figure 32 D).
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Figure 32. Pharmacological manipulated dose response curves on noise exposed dopamine
release. (A) TBZ/AMPT cocktail relays an effective drug concentration of 1.302 μM. (B)
Quinpirole IC50 effective drug concentration of 0.01328 μM. (C) Sulpiride EC50 effective drug
concentration of 0.1618 μM. (D) 7-OH-DPAT IC50 effective drug concentration 0.02298 μM.
To determine if the effects of the noise exposure impacted the receptor pathway, a series
of unpaired t-tests were performed. A comparison of the effectiveness of quinpirole between
both experimental groups displayed a lack of statistical significance, t(12) = 1.239, p-value =
0.2391. Sulpiride continued to demonstrate a similar lack of statistical significance as well, t(13)
= 1.019, p-value = 0.3266. 7-OH-DPAT displayed a slightly different pattern than the other dose
response curves, however, the unpaired t-test found the difference between the control and noise
exposed groups to be borderline significant, t(11) = 2.134, p-value = 0.0562.
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4.3 Assessing the Impact of Noise on Dopamine Receptor
Distribution in the Inferior Colliculus
Immunocytochemistry was used to examine the impact of loud noise on the dopamine
receptor distribution in the inferior colliculus. Brain slices were mounted and stained, as outlined
in section 3.6.1 of chapter 3. The images of brain slices were composited through a stitching
feature in the confocal microscope’s software to generate a complete coronal cross section of the
slice. Areas of the tissue morphology were assessed in coordination with the Paxinos Rat Atlas to
establish a commonality among each of the tissue sections, so an appropriate comparison could
be made among the control versus noise exposed groups (Figure 33 A). Stained brain sections
utilized Alexa Fluor 488 providing the distinctive green fluorescence (Figure 33 B), and a closer
zoom of the tissue demonstrates an example of the brighter neural cell bodies present (Figure 33
C).

Figure 33. Coronal brain section of the inferior colliculus. (A) Rat brain atlas showing the
region of interest (Paxinos & Watson, 2013). (B) Image of a stitched immunocytochemistrystained section of rodent brain and (C) zoomed region depicting neuron cell bodies. Green:
Alexa Fluor 488.
Each of the stained sections were processed and analyzed using ImageJ software (NIH),
which selectively attributes positive pixel signals with positive antibody receptor staining. The
software was tuned to specifically locate and isolate the individualized pixel signals, then was
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counted to provide an assessment of the number of receptors present. The distribution of the
pixels can also be visualized with the software to yield a sense of where the bulk of these
receptors tend to be located (Figure 34). A minority of slides had the appearance of either cutting
artifacts, from the cryotomy, or residual spots from the mounting medium and could result in
reducing the receptor distribution among the effected slides. However, since 10 slides or more
were used for each group, contribution of these errors on the accuracy of the distribution count
was considered low.

Figure 34. Comparison of ICC-stained brain section with corresponding positive receptor
signals. (A) Sample image of control brain section. (B) Distribution of positive receptor staining
in control subject. (C) Sample image of a noise exposed brain section. (D) Distribution of noise
exposed subject receptors.
The aggregate of the positive signals was gathered under the software and could then be
comparatively examined with statistical analysis. All the stained slides were analyzed first
without regard to their stereotaxic coordinates and compared using an unpaired t-test to evaluate
receptor distribution across the control and noise exposed groups (Figure 35 A). The effect of
harmful noise was found to be statistically significant, t(15) = 3.641, p-value = 0.0024.
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The slides were then segregated according to their associated stereotaxic coordinates for a
more accurate account of the receptor distribution. The anatomic location is determined
according to measurements taken by examining common landmarks on the rodent skull. The
Bregma is a coronal suture across the skull and measures taken beyond this mark are designated
as being positive Bregma, whereas measurements taken before this mark are defined as negative
Bregma. A majority of the slides prepared fell into the -8.72 mm Bregma region and the
comparative statistics were repeated (Figure 35 B). The resulting unpaired t-test also
demonstrated statistical significance in the experimental groups, t(11) = 4.000, p-value = 0.0021.

Figure 35. Comparison of D2 dopamine receptors distributed between control and noise
exposed subjects. (A) Uncoordinated slide comparison found statistical significance according to
an unpaired t-test, t(15) = 3.641, p-value = 0.0024. (B) Slide comparisons at -8.72 mm Bregma
also found significant difference between experimental groups, t(11) = 4.000, p-value = 0.0021.
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CHAPTER 5
DISCUSSION
The characterization of neurochemicals and their role in biological systems requires an
approach that captures the complexity and elegance of neurotransmission. The focus of this study
was to optimize an electroanalytical assay to characterize monoamines, such as dopamine, within
the central auditory system in the rodent brain. The work also provided insight on the impact of
loud noise on monoamine neurotransmission in the hub of central auditory responses and hinted
on possible mechanistic options underlying the noise-induce effect.
5.1 Voltametric Assay to Characterize Dopamine
Neurotransmission in the Inferior Colliculus
The operational effectiveness of any instrumental technique is contingent on its
performance characteristics. Fast scan cyclic voltammetry (FSCV) is a sensitive and high
temporal resolution analytical technique that has a wide application in biological systems. Like
all other analytical methods, it was expedient to validate the FSCV assay to establish its fitness
of purpose and to optimize the operational parameters before the slice measurements. The
process also offers the opportunity to resolve possible analytical challenges that the complex
biological environment may pose. FSCV was coupled with carbon fiber microelectrodes made
in-house. The optimization and validation of the method included electrode conditioning and
characterization using a flow-cell based FSCV system. Through continuously cycling the
waveform potential at a higher frequency than the recording frequency, the surface of the carbon
fiber was altered to improve the electrode’s sensitivity. Once conditioned, the electrode
demonstrated increased sensitivity towards electroactive analytes within the potential window of
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the applied waveform. Each carbon fiber microelectrode was characterized to ensure that it
maintained an optimal selectivity and sensitivity. Dopamine, being the chief analyte in this study,
was used in the characterization and optimization of the operational parameters for the analytical
system. The cyclic voltammogram generated provided a characteristic signature for the analyte
and enabled it to be identified by means of the shape of the voltammogram and the location of
the redox signals. Dopamine exhibited an oxidation peak at +0.6 V and a reduction peak at -0.2
V. Furthermore, developing a standard calibration curve established a relationship between the
instrumental response (peak current) and the analyte concentration. The use of regression
analysis provided sufficient evidence of a linear relationship between the analyte and the
instrumental response. The regression analysis also allowed for other important figures of merit
to be reported. Since monoamine neurotransmission in rodent models involves concentrations
near the micro to nano molar ranges, it was expedient to demonstrate the ability of the analytical
system to achieve limits of detection and quantification within or below this range. Our flow-cell
based FSCV-microelectrode system indicated a limit of detection of 0.2 nM and a limit of
quantification at 0.5 nM. Monoamine quantification technique, in vivo microdialysis paired with
High Performance Liquid Chromatography (HPLC), has been reported to have a limit of
detection of ~180 pM and limit of quantification ~1000 nM (M. Zhang et al., 2014). While the
limit of detection is on the same order of magnitude as the current method, the limit of
quantification of the latter is inferior to the former. Issues typically emerge when attempting to
generate an adequate linear dynamic range for quantifying analytes at this low of a concentration
due to the contribution from interferents that include metabolites in the monoamine pathway and
other biomolecules. While derivatization reactions are typically used to improve the
chromatography separation, the technique only provides quantitative measures of the
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extracellular levels of the neurotransmitter rather than its release. FSCV on the other hand, has a
unique ability to measure neurotransmitter release and uptake on a millisecond time scale.
Additionally, the probe size used in the collection of monoamine samples in in vivo
microdialysis is large and disruptive often leading to tissue damage and immune response that
can confound the measurement (Chefer et al., 2009). FSCV maintains optimal detection and
quantification limits, while providing superior spatial resolution and biocompatibility due to the
use of smaller size carbon fiber microelectrodes. In FSCV, the selective nature of the waveform
also discriminates against the other electroactive species present, as they may not undergo redox
reactions within the same potential window selected (Gaweska & Fitzpatrick, 2011).
Ascorbic acid is a common antioxidant in the brain that can typically be an interferent in
electroanalytical measurements in biological environments. The ability of the method to
discriminate between the analyte (dopamine) and potential interferents, including ascorbic acid,
establishes the method’s selectivity. The full potential window of ascorbic acid ranges from -1.0
to +0.8 V, which does have overlap with dopamine. The cyclic voltammogram, however,
displays a different oxidation peak potential, ~+5.5 V, and no reduction peak. The shape of the
voltammogram is markedly different, with a single oxidation peak appearing due to the
irreversible redox reaction occurring at the electrode surface. A comparison of the
voltammograms for dopamine and ascorbic acid provides a clear distinction in their identities.
Dopamine maintains a reduction peak at -0.2 V and an oxidation peak at +0.6 V. These features
provide a general foundation towards distinctively differentiating between these two analytes.
Regression analysis performed on the ascorbic acid calibration curve also confirmed the
calibration sensitivity of the method. Furthermore, the detection and quantification limits for the
ascorbic acid were 1.2 nM and 4.8 nM, respectively. The low limits of detection and
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quantification for dopamine indicate the method’s capabilities of being more sensitive towards
the monoamine than ascorbic acid. Alternative ascorbic acid quantification methods, such as
capillary electrophoresis and HPLC display limits of detection and quantification in the lower
μM to high nM range (Gazdik et al., 2008; Wu et al., 2007). Both methods run into similar
difficulties of sensitivity and selectivity.
Other optimization parameters of the considered was the scan rates of the waveform for
each of the analytes. Each of the experiments did not find any better scan rate for the two
analytes other than the previously established rate in the literature of 400 V/s and were not
included as part of the optimized parameters of this study.
5.1.1 Voltammetry Implementation
in Brain Slices
The complex chemical environment of biological tissues creates a wide range of potential
detection and quantification challenges, requiring an analytical method capable of circumventing
them. The strength of FSCV mentioned and demonstrated in the flow cell system make the
method well positioned for brain measurements. FSCV measurements were made in brain slices.
The advantage of performing FSCV on a brain slice is that the neural cell bodies have been
mechanically detached from the terminal region in the brain slice, allowing for studies that are
more focus on the dynamics at the axon terminal region. The influence from other brain regions
becomes excluded leaving only the brain region of interest to be explored. Additionally, the
application of pharmacological manipulations is much easier in brain slices than in vivo with
minimal washout time required.
Using the parameters established by the flow cell calibrations, the electrodes were
conditioned and pre-calibrated for slice measurements. Stimulation parameters employed were
consistent with previous literature values (John & Jones, 2007). The delivery amperage could be
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adjusted while attempting to establish a stable monoamine signal but was most often centered
around 1 mA. Calibrated and conditioned electrodes ensures that optimization parameters of
sensitivity and selective are maintained. Although the fabricated electrodes will inevitably have
variations, they will also yield variable calibration factors that is essential towards making the
conversion of the collected currents into concentration.
5.1.2 The Tale of Two Peaks
FSCV performed in the inferior colliculus of rat brain slices generated an unexpected
presentation of two oxidation peaks and a single prominent reduction peak. While one of the
oxidation peaks and the reduction peak had striking resemblance with the dopamine
voltammogram, there appears to be a shift of these peaks from the expected potentials. Currently,
much is not known about simultaneous detection of multiple biomolecules in the brain with
FSCV. However, a shift in the oxidation and reduction peaks of a cyclic voltammogram is
common, especially, when measurements are conducted in complex chemical environments.
Adsorption of electrochemically inert materials may alter the presentation of expected peaks.
The same as contributions from other interferants, such as pH and other charged ions like
calcium (Takmakov et al., 2010). It is also possible that the appearance of these peaks is
indicative of electrical artifacts. Despite these effects, the FSCV software can provide a
multivariate calibration through the construction of training sets as applied through principal
component regression analysis to determine analyte concentration (Keithley & Wightman, 2011).
In addition, Fourier transformations are available in the FSCV instrumental software package as
a means towards filtering and smoothing the data (Bucher et al., 2013). The effect of this
filtering allowed for the isolation of one of the oxidation peaks which further reflected a change
in the shape of the cyclic voltammogram, appearing more aligned with the typical dopamine
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signature. The voltammogram combined with the training set analysis provided the first degrees
of evidence that suggest dopamine was being recorded in the inferior colliculus. To confirm this
assertion, the brain slices were pharmacologically manipulated to examine the impact on the
analytical signal.
Pharmacological manipulations are a common addition to FSCV analysis and are integral
in identifying, confirming, and characterizing a detected analyte (Brodnik et al., 2020). First the
brain slices were challenged with tetrabenazine, a drug that inhibits vesicular monoamine
transporter 2 (VMAT 2). This transporter packages monoamines, such as dopamine and
norepinephrine, into vesicles upon synthesis and are stored until they are released during
neurotransmission. The perfusion of tetrabenazine demonstrated concentration-dependent
attenuation in signals for the two oxidation peaks, suggesting them to be signals from
monoamines. Further pharmacological studies with drugs that are selective for dopamine
receptors, such as quinpirole (D2 receptor agonist), sulpiride (D2 receptor antagonist) and 7-OHDPAT (D3 receptor agonist), also yielded a dose-dependent decrease in the peak 1 signal, but not
much alteration in the peak 2 signal. These data provided sufficient evidence to conclude the
identity of peak 1 to be dopamine, an inference that is consistent with the Fourier
transformations. The data also implicates norepinephrine as a possible candidate responsible for
peak 2. Norepinephrine is a well-known monoamine neurotransmitter synthesized from
dopamine by dopamine β-hydroxylase. Existing data have demonstrated the presence of this
monoamine in the inferior colliculus by HPLC (Browning et al., 1991). Additionally, the inferior
colliculus has also been shown to contain noradrenergic receptors (Klepper & Herbert, 1991),
suggesting that norepinephrine plays a role in auditory processing.
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5.2 Characterizing the Effect of Loud Noise on
Monoamine Neurotransmission
Exposure to loud noise can cause deafness and other hearing disorders, including tinnitus.
While existing work has demonstrated that deafening noise elicits changes in spontaneous
neuronal activity in key auditory brain regions, including the inferior colliculus, the exact neural
substrate is not known. As dopamine is now implicated in the auditory process, we examine how
loud noise impacts on its transmission in the hub of auditory processes. The present data revealed
significant reduction in dopamine release 24-hours following noise exposure., implicating
dopamine neurotransmission in noise-induced deafness related changes in the inferior colliculus.
Sex differences have the potential to influence a variety of chemicals throughout the body and
were considered a possible variation in this study. However, the analysis of the subjects
separated by sex ultimately found that no inherent difference was present (see Appendix A). The
effect of noise appears to be long-lasting, as changes in dopamine release persisted three days
after noise exposure.
The appearance of both oxidation peaks remained present in the sound exposed subjects.
Pre-calibration training sets were developed for dopamine, as previously outlined in section
5.1.1., and the current signals were converted into concentration. Since norepinephrine was not
originally expected, a single pre-calibrated training set established for the control subjects was
extended for use in the noise exposed subjects to retain the consistency of the current to
concentration conversion. Filtering of the data was also consistent for the noise exposed subjects
as it had for the control subjects, effectively verifying the continued presence of both
monoamines after exposure to harmful noise. The effects of the noise exposure displayed clearly
depressed signals in both monoamines. The extent of the decrease in the release of these
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monoamines elicited by the noise exposure provides evidence of the connection that they have in
hearing.
5.3 Plausible Mechanism for Deafness Related
Changes in Monoamine Neurotransmission
Due to the noise-induced decreased in dopamine release, we hypothesized this effect
could be elicit via the feedback inhibition loop. The mechanism occurs through three primary
stages. First, inhibitory dopamine autoreceptors decrease vesicular release through activation of
calcium channels which lowers the amount of calcium entering the neuron. Next, autoreceptors
also increase the activity of plasma membrane proteins, which increase the rate of reuptake back
into the neuron, decreasing the concentration of dopamine within the neural synaptic space.
Finally, any long term activation of the autoreceptors results in a decrease in activation of
tyrosine hydroxylase, which ultimately results in a further decrease in the synthesis and
packaging of monoamines in the neuron’s vesicles (Ford, 2014). To verify the present
hypothesis, the effect of noise on three main targets within the feedback inhibition loop was
examined, namely the D2 autoreceptors, dopamine synthesis, and packaging into vesicles.
Modulation of dopamine receptor genes in auditory processing following acoustic
damage in the inferior colliculus has been reported by previous work (Gittelman et al., 2013b),
yet a direct comparison of D2 receptors in noise exposed subjects has not been previously
characterized. The D2 autoreceptors functionality was examined using FSCV and pharmacology.
Changes to the dopamine autoreceptor (D2 and D3) inhibitory action would support the feedback
inhibition as a plausible mechanism of the effect of noise. Repeats of the drugs selective for
dopamine receptors; quinpirole, sulpiride, and 7-OH-DPAT yielded a similar response to the
control studies. Statistical analysis comparing the control and noise exposed groups found there
was no significant difference in the response to the drugs. This data provides enough evidence to
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conclude that noise did not impact dopamine autoreceptor (D2 and D3) functionality directly.
The possible impact of noise on dopamine receptors was further explored by comparing their
distribution after the noise exposed. Immunocytochemistry was used to accomplish this goal.
Immunocytochemistry allows for the distribution of the receptors in the region of interest to be
studied. Comparisons of the distribution of positive receptor staining in the inferior colliculus
showed a greater density near the central nucleus. A major processing and integration center of
auditory information, the central nucleus of the inferior colliculus receives input from the
ascending auditory pathway (Goyer et al., 2019). The significant difference presented between
the control and noise exposed subjects suggests that noise exposure alters D2 receptor
distribution in the inferior colliculus. A difference in the distribution of the autoreceptors
challenges the feedback inhibition loop hypothesis, since the number of receptors were reduced,
and the functionality was not altered. This suggests that the damage from noise is more
widespread and multifaceted.
The large reduction in monoamine release further implicates the impacts of noise on
monoamine synthesis and packaging as both neurotransmitters are linked through this pathway
and both were affected. Alpha-methyl-p-tyrosine (AMPT) operates by inhibiting tyrosine
hydroxylase, the rate-determining enzyme in monoamine synthesis. This was combined with
tetrabenazine, which inhibits vesicular transport to the synapse, to further study the depletion of
monoamine release. The drug perfusion followed suit with the control experiments generating a
drug response curve that displayed a steeper slope than tetrabenazine alone, representing the
extent to which the inhibition had taken place. Modulation to the synthesis and vesicular
packaging produced similar levels of inhibition to both dopamine and norepinephrine, suggesting
the effects of the noise damage are likely coming from something not directly linked to the
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synthesis and packaging pathway. Existing evidence may implicate oxidative stress as a potential
mechanism underlying the effect of noise the monoamine release. Oxidative stress involves
excessive production of reactive oxygen species that emerged from the chemical stress being
imposed on the nervous system during periods of exposure to harmful levels of noise.
5.4 Conclusions and Recommendations
for Future Study
The primary aim of this research was to assess the impacts of harmful noise on
monoamine neurotransmission in the hub of central auditory responses. To accomplish this task,
there was the need to identify and optimize an analytical method to detect and monitor
monoamine release. Next, the technique was utilized to compare monoamine transmission
between control versus noise exposed groups. Finally, the potential underlying mechanisms
behind the effect of noise was explored.
5.4.1 Conclusions from
Objective 1
Fast scan cyclic voltammetry was selected as an appropriate method to characterize
electroactive monoamines in the brain due to its speed, sensitivity, selectivity, and its ability to
utilize microelectrodes to make measurements from sub-anatomical brain regions. The complex
biological and chemical makeup of the brain required optimization of the FSCV assay using
flow-cell analysis. The optimized parameters established in the flow-cell calibration and
characterization were incorporated in the slice monoamine measurements. Two oxidation peaks
in the cyclic voltammograms were detected and identified to be dopamine and norepinephrine,
using FSCV and pharmacological manipulations. Thus, this work reports simultaneous detection
of these monoamines in the inferior colliculus.
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5.4.2 Conclusions from
Objective 2
FSCV measurements were made from the inferior colliculus of rats that were exposed to
harmful levels of noise to invoke deafness. The presence of both oxidation peaks remained
following noise exposure. Concentrations of both dopamine and norepinephrine released were
found to be significantly reduced in the noise exposed groups compared to their controls. This
effect of noise on dopamine neurotransmission was demonstrated to be long-lasting.
Confirmation of both analytes were assessed with training sets established using the analysis
software’s principal component regression capabilities.
5.4.3 Conclusions from
Objective 3
The feedback loop mechanism was tested as a means towards explaining the reduction in
neurotransmitter release following exposure to harmful noise and tested through analysis of
dopamine autoreceptors, dopamine synthesis, and vesicular packaging. The distribution of
receptors was found to be significantly different among experimental groups. Pharmacological
manipulation of receptor functionality was also not significantly impacted. Further modification
of the synthesis pathway with pharmacological agents displayed no significant impact in the
effectiveness of the neurons to package or synthesize monoamines. The impact of noise on the
concentration of monoamine release must be resulting from another source, possibly through
oxidative stress mechanism.
5.4.4 Overall Conclusions
The present work presented FSCV utility in flow-cell and in brain slices. The method
demonstrated high sensitivity, selectivity, and limits of detection and quantification. The
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application of the method in brain slices allowed simultaneous measurement of monoamines
whose identities were verified to be dopamine and possibly, norepinephrine used with
pharmacological studies. This work also demonstrated for the first time that deafening noise
downregulates monoamine neurotransmission in the inferior colliculus, an effect that was proven
to be long-term. While this noise-induced effect in the hub of auditory responses did not appear
to involve direct alteration in VMAT 2 and dopamine autoreceptor function; the distribution did
present a significant difference among experimental groups. The role of the feedback inhibition
loop is less likely, and the effects of damaging noise are more widespread throughout the brain.
5.5 Future Directions
Detection of multiple electroactive analytes by FSCV simultaneously has not been
previously reported. The early findings in this study open the door to many other applications
that may extend beyond a biological system. Limitations in the instrumental software made it
difficult to isolate the signals from one another and could be improved upon to enhance
selectivity between the two monoamines in slice measurements. Furthermore, instrumental
innovations to FSCV could employ electrode modifications to delineate between the dual
detection of analytes.
The identification of dopamine and norepinephrine in the inferior colliculus implicates
both monoamines in central auditory processes. Norepinephrine was suspected as a co-detected
analyte through the process of exclusion and the effects of dopamine-related pharmacology.
More pharmacological studies should be employed at specifically targeting norepinephrine and
related receptors in the inferior colliculus. Further studies should also expand the exact roles of
these neurotransmitters on the central pathway and their possible connections to the peripheral
auditory systems. The extent and role to which these monoamines operate may also provide
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clinicians with a route towards developing effective therapeutic interventions for hearing-related
disorders, including hearing loss and tinnitus.
The role of dopamine in auditory processing remains an open field for investigation. This
study can extend into behavioral and learning effects of hearing. An overall distribution of the
D2-like receptors in the inferior colliculus was changed, the impact of noise on the feedback
inhibition mechanism may still be tested further. Few options are possible towards explaining the
mechanism underlying the noise-induced attenuation in monoamine transmission, including
oxidative stress that should also be explored. These new steps may shed more light on the role
monoamines play in auditory neural signaling.
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APPENDIX A

MONOAMINE COMPARISON IN THE
INFERIOR COLLICULUS
BY GENDER
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Figure 36. Comparison of gender on monoamine release in the inferior colliculus. (A) Dopamine
release by gender displayed no statistically significant difference, t(8) = 0.5576, p-value =
0.5924. (B) Norepinephrine release by gender found no statistically significant difference, t(8) =
0.5366, p-value = 0.6061.
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APPENDIX B
PHARMACOLOGICAL CONCENTRATION VS TIME
TRACES OF NOISE EXPOSED SUBJECTS
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Figure 37. Noise exposed brain slice perfused with TBZ and AMPT cocktail. (A) Effect of drug
cocktail on dopamine neurotransmission yields decreased peak concentration release with
increasing drug concentration perfusion. (B) Impacts of the combination drug cocktail on
norepinephrine neurotransmission indicating decreased peak concentration release related with
increasing drug concentration perfusion.

Figure 38. Effect of quinpirole on noise exposed subject group. (A) Dopamine peak
concentration decreases with increasing drug concentration. (B) Norepinephrine peak
concentration remains consistent with changing drug concentration.

Figure 39. Effect of sulpiride on noise exposed subject group following quinpirole perfusion.
(A) Dopamine peak concentration increases with increasing drug concentration. (B)
Norepinephrine peak concentration is maintained with changing drug concentration.
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Figure 40. Effect of 7-OH-DPAT drug perfusion on noise exposed subject monoamine peak
release concentration. (A) Peak dopamine release concentration decreases with increasing drug
concentration. (B) Peak norepinephrine concentration stays consistent with changes in 7-OHDPAT perfusion concentration.
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APPENDIX C
NOISE EXPOSED NOREPINEPHRINE
DOSE RESPONSE CURVE
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Figure 41. Effects of pharmacological agents on sound exposed norepinephrine subjects. (A)
Noise exposed subject effective quinpirole concentration on norepinephrine peak concentration
release was 0.002954 μM. (B) Noise exposed subject effective sulpiride concentration on
norepinephrine peak concentration release was 0.001026 μM. (C) Noise exposed subject
effective 7-OH-DPAT concentration on norepinephrine peak concentration release was 0.1007
μM.

